A Registered Nurse experienced in working with in-patient and outpatient care providers in a team setting consisting of physicians, nurses, physical therapists, occupational therapists, speech therapists and pharmacists, and in the development and purification of cGMP compliant Biopharmaceuticals for preclinical and clinical studies including marketed products. Looking forward to using my professional skills as a Clinical Research
BSN: June 2020
American Sentinel University
Registered Nurse: R218345 August 2015
Associate of Arts in Nursing (ADN) with Honors: May 2015
Howard Community College, Columbia, MD
Ph.D., Physiology: December 1986
University of Manchester, Manchester, UK
B.Sc. Biology (Minor: Chemistry): May 1981 University of Asmara, Asmara, Eritrea
RELEVANT WORK EXPERIENCE: CLINICAL
Nurse Monitor 2015 – Present
POTOMAC HOME SUPPORT INC. (PHS)
(Contractor: for the Department of Health and Human Services)
Administer and complete comprehensive health care assessments to eligible clients in their homes as ordered on the individualized Registered Nurse Monitoring plans of care and monitor each client's health, condition, and safety while providing quality oversight of provider services.
Assessing eligible individuals and completing the assessment tool.
Handling and managing assigned caseloads of eligible individuals, making timely contacts, and providing feedback to all parties as required.
Providing quality oversight of providers in the homes of eligible individuals.
Monitoring clients’ medications when needed.
Liaising with PCPs, families, supports planners, and County health workers.
Reporting to Potomac Health Services, support planners, and the County staff any incidents/observations of unusual nature (such as a Reportable Event situation)
Loading assessment information into a Long-Term Services and Supports (LTSS) database within 48 hours of completion of the assessment.
RN Case Manager Mar 2018- April 2020
AMEDISYS HOME HEALTH
Provided, coordinated, and direct the provision of home nursing care according to physician's orders based on agency policies and procedures using the nursing practice
Visited patients, reviewed and reconciled medications, assessed and evaluated patients’ progress, supervised LPNs, and Home Health Associates
Educated and then obtained informed consent from patients
Performed patient comprehensive assessments and collaborated with patients’ multi-disciplinary care team consisting of Physical Therapists, Occupational Therapists, Speech Therapists, Medical Social Workers, and other health care professionals to develop/modify/implement an individualized plan of care per physician orders to ensure quality, proper discharge planning, and desired outcomes and goals.
Helped to achieve and maintain continuity of patient care by communicating information (for example, changes in the plan of care, new orders, lab results, etc.) timely, effectively, and systematically with all team members providing care to the patient
Facilitated interdisciplinary communication, feedback, and follow-up through care coordination on assigned patients and/or caseloads of patients for the duration they are on service
Regularly attended weekly team meetings, update team, and upper management on relevant patient progress and management
Recommended and make referrals to other disciplines as indicated by the patient's needs or document rationale for not doing so
Utilized a combination of care center resources and recognized standards of practice to achieve positive clinical outcomes
Participated in clinical outcomes monitoring, follow-up on care center performance improvement initiatives.
Initiated, planned, and provided staff education as needed
Utilized accepted company teaching materials for patient/family/significant other education
Reported and complete reporting of adverse events accurately and timely manner
Documented findings on time and accurately at the point of care, according to industry standards, and guidelines, including Outcome and Assessment Information Set (OASIS), Start of Care (SOC)/Admissions, Recertifications, Advance Beneficiary Notice of Noncoverage (ABNs), subsequent visits, physician orders, care coordination
Critical Care Nurse II Telemetry, Med/Surg, Neuro/Stroke Unit Sept. – Dec. 2017
ST AGNES HOSPITAL, Baltimore MD
Performed admission assessment of patients.
Prepared patients for stress testing, echocardiograms, peripheral diagnostic studies, cardiac catheterization procedures, and the operation room.
Received patient's from Catherization lab and performed an appropriate assessment for vital signs, affected limb, insertion site, and restriction in activity immediately after the procedure.
Prepared and administered oral, rectal, NG/PEG tubes, SUBQ, IM, IV, recorded prescribed medications, and evaluated patient's response to clinical intervention and progress toward goals.
Monitored patients with cardiac conditions such as chest pains, arrhythmias, CVA, MI, post-infarct, and identified heart rhythms such as a-Fib, heart blocks, v-Tach/Fib and reported to the physician for clinical treatment.
Participated in a multidisciplinary team of medical professionals to assess, evaluate, and diagnose patients and develop effective treatment plans under the direction of the physician
Acted as a patient advocate; interacted in a timely manner between multidisciplinary staff to minimize delays and optimize patient care and efficiency.
Modified and individualized nursing care according to the patient, family, and significant other based on the culture, demographics, history, needs, and provided patient, family, and significant others education in disease states, expectations, medications, and home health care.
Documented through electronic notes regarding patient care and status during shift.
Coordinated patient discharge plans with the healthcare team and provided patient, family, and significant others guidance and support in illness management, medication, and side effects, diet, nutrition, exercise, and follow-up appointments.
Managed and provided clinical direction to CNAs.
Registered Charge Nurse, Rehab- Med/Surg Sept. 2015 to May 2017
HEBREW HOME OF GREATER WASHINGTON, Rockville MD
Supervised all nursing activities on the assigned unit
Observed and evaluated residents’ physical and emotional status
Administered oral, rectal, Nasogastric/ percutaneous endoscopy gastrostomy tubes, subcutaneous, intramuscular, intravenous medications
Treated wounds per physician order, evaluate and reported wound healing progress
Reviewed medication records and clinical intervention records for completeness of
information, accuracy in the transcription of physician orders, and effectiveness of medications, and/or treatment
Reviewed lab results and informed patients and designated family members/significant others
For admissions, discharge, and transfer of patients from one unit to the other, completed required documentation using the electronic medical record system
Assured the client’s plan of care was being followed
Effectively delegated responsibilities for the direct care of specific residents
Arranged schedule to allow time for supervision and evaluation of performance of all nursing personnel on the unit
Kept the Nurse Manager informed on the status of residents and other related matters through written reports and verbal communication
Provided direct resident care as needed
Collaborated with social workers, physical/occupational therapists, dieticians, and quality control
Scientist (Contractor) August–October 2011
MEDIMMUNE – Frederick, Maryland
Qualified downscale model chromatography steps (affinity, anion exchange, and cation exchange) and viral filtration step for the purification of recombinant monoclonal antibodies for clinical use
Enabled the CMO to transfer the downscale model to manufacturing scale to produce product for Phase III clinical trials
Diploma (in ICH, GMP, GLP and GCP Guidelines) Dec. 2008–May 2009
KRIGER RESEARCH CENTER INTERNATIONAL Inc. (KRC) Canada
Quality assurance, GMP, GCP, and GLP; processing operations, in-process control, statistical quality control, control of pharmaceutical products including product testing, experimental techniques and technical documentation, knowledge of ICH GCP guidelines training for laboratory and manufacturing environment, application of GMP, ICH, FDA and TPD guidelines relative to quality issues, generating audit and non-conformance reports for in-line and in-process tests in both manufacturing and laboratory settings; preparation of protocols, SOP's, and other technical documents in accordance to in-house, compendial and regulatory requirements
Internship with KRC Inc.:
Prepared the audits of the QC lab with a primary focus on reviewing laboratory records.
Generated a raw material specification and a finished product specification for Product rhEGF for the USA
Prepared testing and limits meeting the requirements of the USP monographs.
Wrote sampling documents specifying the amounts of raw material and finished products required to conduct full testing.
Compiled concise report outlining the submission requirements,
Wrote a detailed SOP detailing the use of specific manufacturing equipment and laboratory apparatus.
Created a flow chart outlining the processes and critical controls involved in a pharmaceutical environment from the time raw materials are received, to the manufacture of the product, and the shipping of the finished packaged product to consumers for use and applied the GMP, GLP and GCP regulations in the activities listed above.
Scientist II Dec. 2004 – Dec. 2007
PDL BIOPHARMA – Brooklyn Park, Minnesota
Involved in manufacturing process steps of biotechnology derived monoclonal
antibody products for Crohn’s disease from cell culture clarification to formulation
Wrote/reviewed technical reports for products clinical manufacturing campaign
AVENTIS BEHRING – Bradley, Illinois Jul. 1995 – Jun. 2004
Manager, Plasma Derived Coagulation Products 2002 – 2004
Implemented manufacturing process improvement protocols to increase product quality and yield.
Lead the reformulation efforts to reduce the polymer content of marketed coagulation products.
Facilitated and participated in meetings with upper management, collaborators, and quality assurance auditors
Reviewed manufacturing protocols and operating procedures
Member of corrective and preventive action plans (CAPA) including for manufacturing deviation
Research Scientist / Senior Development Scientist March 1997 – March 2002
Qualified product intermediates to be shipped and manufactured at different sites.
Developed and qualified scaled-down models for chromatographic process steps.
Collected and analyzed purification process data and wrote protocols, reports, and presented results to upper management.
Postdoctoral Fellow July 1995 – March 1997
Developed and established in-vivo animal model studies to evaluate the efficacy of products in development.
Reviewed Pharmacology and Toxicology supporting protocols, collected data, and final reports for Investigational New Drug (IND) submission.
Reviewed Pharmacology and Toxicology supporting protocols, collected data, and reports for studies performed by contract laboratories.
ACADEMIC RESEARCH EXPERIENCE
Research Scientist Nov. 1992 – Jun. 1995
University of Chicago, Chicago IL
Established an in-vitro model for maternal-fetal transfer studies across the
perfused human placenta
Postdoctoral Fellow Nov. 1986 – Dec. 1988
University of Cincinnati, Cincinnati, OH
• Established and in-vitro model for the maternal-fetal effect of serotonin, angiotensin II, prostaglandins and thromboxane on the perfused human placenta
Adjunct Professor – Chemistry Spring 2013
Howard Community College, Columbia, MD
Adjunct Professor – Biology Fall 2009 - Spring 2011
Montgomery College, Germantown, MD
HONORS AND AWARDS
•Howard Community College Dean List, Columbia, Maryland, USA
•Nestle Nutrition Research Program, University of Manchester, United Kingdom
•ORS (Overseas Research Student) Award, University of Manchester, United Kingdom
•University of Asmara Fellowship (U.N.D.P.), University of Asmara, Eritrea
Kahsai, T.Z., Roth, N.J., Zhao, Y., Gallagher, C.N., Boreisha, I., Berhe, A., Read, M. Taylor, K., Bode, A., Blajchman, M., Balshuweit, G., Brown, L., Summaria, L.J., Huang, C.C., Flanigan, E., and Feldman, F. (1995). Development of a pilot scale protocol for the preparation of lyophilized human platelets that retain physiological integrity and hemostatic functionality. Blood, J. of American Society of Hematology, Vol. 86, (No. 10) Supplement 1. No. 1406.
Berhe, A., Smith, T., Clark, K., and Myatt, L. (1989). The effect of calcium concentration on vascular reactivity in the perfused human placental cotyledon. Society for Gynecological Investigation.
Berhe, A., Harkes, A., and Sibley, C.P. (1988). Effects of histamine on vascular resistance and protein permeability in the isolated dually perfused guinea pig placenta. J. Dev. Physiol. 10:357-69.
Myatt, L., Berhe, A., Guilitto, R., and Brockman, D. (1988). The relationship of perfusion pressure to eicosanoid production in the human placental cotyledon. 6th International Congress of International Society for the Study of Hypertension in Pregnancy. Montreal, May 22-26.
Berhe, A., Bardsley, W.G., Harkes, A., and Sibley, C.P. (1987). Molecular charge effects on the protein permeability of the guinea pig placenta. Placenta 8: 365-380.
Berhe, A., Harkes, A., and Sibley, C.P. (1987). Microvascular effects of histamine in the dually perfused guinea pig placenta. J. Physiol. 387:70P.
Berhe, A., Harkes, A., and Sibley, C.P. (1986). Differential effects of histamine on the permeability of the dually perfused guinea pig placental to anionic and cationic HRP. Placenta 7:460.
Sibley, C.P., Berhe, A., and Harkes, A. (1986). Histamine affects the protein permeability of the dually perfused guinea pig placenta. I.U.P.S. Congress Proceedings p.99.
Berhe, A., Harkes, A., and Sibley, C.P. (1985). Effect of molecular charge on guinea pig placental permeability; Quantitative measurement using horseradish peroxidase (HRP). J. Physiol. 369: 155p.
Berhe, A., Harkes, A., Sibley, C.P. (1984). Quantitative measurement of placental protein permeability. European Placental Group
L. J. Summaria, A. Berhe, N. Roth, M. Even. Method for preparing a diafiltered stabilized blood product. PCT Int. App> WO ((55,346 (Cl.A61K35/14), 4 Nov. 1999, US Appl.66, 694, 27 Apr 1998; 38pp. In CA Selects: Formulation Chemistry. Issue 25, p 14, 1999.